TNBC: Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OS compared to neoadjuvant chemo alone

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC

Breastfeeding after breast cancer is safe

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HER2 positive early BC

Intraoperative radiotherapy at Fortis Healthcare Hospital

Intraoperative radiotherapy: Techniques, applications, and evidence

Assessment of suicide risk in cancer patients

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer

Cancer journeys: Research from India

Depression in cancer